Evaluation of Clinical Outcomes of Prostatic Urethral Lift for Benign Prostatic Hyperplasia: An Asian Population Study
Purpose: This study aimed to assess the clinical outcomes of prostatic urethral lift in Korean patients with bothersome lower urinary tract symptoms due to benign prostatic hyperplasia (BPH). Materials and Methods: Thirty-two men with symptomatic BPH were consecutively treated in a tertiary care c...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean Society for Sexual Medicine and Andrology
2020-07-01
|
Series: | The World Journal of Men's Health |
Subjects: |
Summary: | Purpose: This study aimed to assess the clinical outcomes of prostatic urethral lift in Korean patients with bothersome lower
urinary tract symptoms due to benign prostatic hyperplasia (BPH).
Materials and Methods: Thirty-two men with symptomatic BPH were consecutively treated in a tertiary care center in Korea.
To be included in the present analysis, patients had to meet the following criteria: age ≥50 years, International Prostatic
Symptom Score (IPSS) >12, and prostate volume between 30 mL and 80 mL. Patients were evaluated up to a median followup
period of 1 year post-procedure. The primary outcomes included symptom relief, improvement of quality of life (QOL),
and preservation of sexual function.
Results: All procedures were finished with a mean of 2.2 implants without any serious complication. The numbers of patients
diagnosed with diabetes mellitus, hypertension, and ischemic heart disease were 16 (50.0%), 24 (75.0%), and 9 (28.1%), respectively.
Patients experienced symptom relief by 1 week that was sustained for 12 months. The mean IPSS, QOL, and maximum
flow rate improved to 43%, 70%, and 25% by 1 week, and to 41%, 60%, and 32% by 12 months (p<0.001), respectively.
There were no occurrences of early urge incontinence, retrograde ejaculation, or erectile dysfunction. Patient-reported
adverse events were mild and transient.
Conclusions: Prostatic urethral lift is a safe and effective treatment for BPH in the Asian population. This treatment is minimally
invasive, can be performed under local anesthesia, and may be an appropriate method for fragile patients. |
---|---|
ISSN: | 2287-4208 2287-4690 |